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Sarcoidosis is so rarely seen in residents of Hawaii that it 
may rzot be considered as a diagnostic possibility. The differ-
ential diagnosis is more complex in Hawaii due to the pres-
ence of granulomatous diseases such as tuberculosis and lep-
rosy. We present the first known case of sarcoidosis in a 
Hawaii resident together with an overview of the disorder. 
Introduction 
Sarcoidosis is a noncaseating, granulomatous disease 
which can affect virtually any organ system. A high percent-
age of patients undergo spontaneous resolution. 
Sarcoidosis is common in certain areas of the U.S. and its 
clinical presentation is well known to most physicians there. 
The disease is rare in Hawaii and, therefore, may not be easy 
to diagnose at first glance. Complicating the diagnosis is the 
fact that other entities in the differential diagnosis are far more 
prevalent in Hawaii than on the Mainland. For instance, more 
cases of leprosy and Mycobacterium tuberculosis are seen in 
Hawaii, yet on the Mainland these diseases are rarely seen. In 
addition, granulomatous reactions to plants (particularly cac-
tus and bromeliads), insects and sea urchins are commonly 
encountered in Hawaii and may simulate sarcoidosis. 
We recently diagnosed the first case of sarcoidosis occur-
ring in a long-standing resident of Kauai. The clinical findings 
were subtle and the diagnosis was not immediately obvious. 
Case report 
A 40-year-old woman presented to one of us (DJE) with 
small, somewhat painful nodules on the extensor aspects of 
both forearms that had been present for 4 months. 
The patient was born in Portugal, where she had resided for 
the first 16 years of life; thereafter she lived in Mozambique. 
Later on, she emigrated to Kauai, Hawaii, where she has 
resided for the past 13 years. 
The patient's past medical history was unremarkable. She 
was a para III, the last pregnancy having been in 1982, at 
which time she had undergone an elective bilateral tubal liga-
tion. She had had a similar skin eruption on both forearms in 
1988 which had resolved in 4 months. At that time, a chest X-
ray was normal (Fig. I). 
The patient and her husband are farmers. Two months prior 
to her presenting herself to us, several red, tender nodules 
appeared on the anterior aspects of both lower legs. They dis-
appeared in a few weeks. There were no other symptoms, 
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specifically no respiratory difficulties and no visual com-
plaints. 
The physical examination was remarkable for several ery-
thematous, flat-topped papules and plaques measuring 2 to 15 
mm in diameter, arranged in an almost symmetric fashion on 
the extensor surfaces of both forearms. A barely visible circi-
nate lesion measuring 8 em in diameter was present over the 
anterior surface of the lowermost portion of the right leg. 
A 3 mm punch biopsy of one forearm lesion revealed 
closely-packed, noncaseating epithelioid granulomas confined 
primarily to the upper dermis (Figs. 3, 4). The granulomas 
were bordered by a moderate lymphocytic infiltrate. A few 
multinucleated giant cells were present, including a rare Lang-
hans cell. Birefringent particles were not identified under the 
polarizing lens. Fungal elements were not identified with the 
PAS stain and the AFB stain was negative. These findings 
were interpreted as consistent with sarcoidosis. However, nei-
ther leprosy nor a foreign body reaction (including to cactus 
Fig. 1 Normal baseline chest X-ray, 1988. 
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and similar plants, sea urchins, and insect bites) could be ruled 
out by histologic methods alone. 
A chest X-ray revealed prominent, left hilar adenopathy and 
possible right hilar adenopathy as well (Fig. 2) . Pulmonary 
function tests were normal; sputum culture was negative. 
Laboratory studies (including calcium), urinalysis, and 
CBC were all within normal limits. Angiotensin Converting 
Enzyme (ACE) was 10.4 activity units (normal2.0-7.5). 
The patient was diagnosed as having sarcoidosis and no 
specific treatment was offered due to the mild presentation. 
The lesions on her lower extremities were diagnosed as ery-
thema nodosum. At the time of this report, the skin lesions are 
resolving. 
Discussion: Sarcoidosis 
Our patient demonstrated a mild form of sarcoidosis which 
affects one-quarter to one-third of patients with this disorder; 
they often have with constitutional symptoms that may 
include cough, dyspnea, arthralgias, uveitis and a variety of 
skin lesions. A further one-quarter of patients, especially those 
on the Mainland, are asymptomatic, the disease having been 
discovered on routine chest X-rays. In our opinion, this subset 
may well be even larger, since many so afflicted obviously 
never visit a physician because they have no constitutional 
complaints. 
The remainder of patients have a more insidious onset that 
develops over a period of months. This group is more likely to 
Fig. 2 - Left hilar adenopathy with possible right hilar 
adenopathy. Chest X-ray, 1990. 
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develop chronic disease with subsequent severe pulmonary 
and other organ damage. 
It is quite likely that our patient was exposed to the puta-
tive agent (or agents) of sarcoid before moving to Hawaii, and 
that initiated sarcoidosis after a latent period of at least 13 
years. Speculation concerning this activation process could 
center on poorly understood immunologic and/or genetic 
mechanisms. A further unknown factor acting as a hapten may 
have aided in the recognition of the dormant antigen by the 
patient's reticuloendothelial system. Or, it is possible that this 
new factor- or even the offending agent itself- was geneti-
cally transcribed, its coding system having been unlocked by 
an unknown environmental stimulus. 
Epidemiology 
The highest incidence of sarcoidosis is found in northern 
Europe and in North America. Sweden has the highest inci-
dence of any country, at 6411 00,000; however, according to 
autopsy studies, the true incidence may be I 0 times 
higher'.The incidence in the U.S. is II to 40/100,000, the 
highest being among Blacks in the Southeast. Parts of Africa 
and Japan also show a relatively high incidence. Sarcoidosis is 
rare in southern Europe and in southeast Asia. 
In the U.S ., Blacks are affected 10 to 17 times more often 
than Whites . Black women are affected twice as often as 
Black men, but the sex ratio in Whites is approximately equal. 
The disease is most common in the 3rd and 4th decades of 
Fig. 3 - Skin biopsy demonstrating granulomas in upper der-
mis. Low power. H & E stain. 
Fig. 4- Skin biopsy. Mid power. H & E stain. 
(Continued)~ 
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life. An increasing number of familial cases are being noted, 
most frequently brother and sister1• 
Etiology and pathogenesis 
Extensive studies so far have not elucidated an etiologic 
agent for sarcoidosis1• Many agents have been postulated as to 
the cause. These include Mycobacterium tuberculosis, 
Mycobacterium leprae, atypical Mycobacteria, a variety of 
viruses, fungi, inorganic agents and chemicals; however, the 
data are inconclusive. 
Whatever the inciting event, the histopathogenesis of sar-
coidosis suggests an immunologic basis'. It is postulated that 
an unknown antigen (or antigens) is recognized by a 
macrophage/histiocyte, which then stimulates the proliferation 
of helper T4 lymphocytes, that in turn stimulate B-lympho-
cytes to proliferate. The end-result is a granuloma composed 
of epithelioid histiocytes bordered by T-4 lymphocytes. 
Clinical manifestations 
Ninety percent of patients with sarcoidosis have an abnor-
mal chest X-ray but only 5 to 15% develop serious pulmonary 
disease'. Overall, approximately 50% of patients have respira-
tory symptoms such as a dry cough, chest pain, shortness of 
breath, rarely hemoptysis. Less than 2% develop a pneumoth-
orax. Intraparenchymal pulmonary granulomas have a 
predilection for the peribronchial, subpleural and interlobular 
septal connective tissues. Progressive disease with fibrosis is 
an interstitial process. 
The skin is involved in 20 to 35% of cases•. A great variety 
of skin lesions have been associated with sarcoidosis; the most 
common are plaques, maculopapular eruptions, subcutaneous 
nodules, erythema nodosum and lupus pernio. The first 3 cate-
gories are ubiquitous in distribution. The papular form is most 
frequently located in the periorbital region, where it may sim-
ulate granulomatous rosacea. Erythema nodosum occurs in up 
to 25% of patients and may be the initial symptom. It is most 
commonly located on the anterior aspects of the lower legs 
and presents as tender, erythematous, or violaceous nodules. 
Most patients with sarcoid and erythema nodosum have a 
shortened disease course, with early spontaneous resolution. 
Those with Lofgren's Syndrome (a complex of erythema 
nodosum, bilateral hilar adenopathy, together with possible 
joint symptoms and uveitis) have an excellent prognosis. In 
one study, cases with erythema nodosum, acute arthritis and 
hilar adenopathy resulted in complete resolution of sarcoidosis 
in 85%, 83% and 73% of patients, respectively'. Sarcoid skin 
lesions have been reported in skin scars (including keloids) 
and in skin damaged by trauma, infection and radiation. 
The eye is involved in 25 to 50% of patients with systemic 
disease4 • The most common symptoms are blurred vision, 
tearing, and photophobia. Granulomatous uveitis is the most 
common eye lesion; approximately 75% of these patients have 
anterior uveitis and the remainder have posterior uveitis. The 
clinical course may be acute or chronic. Heerfordt's Syndrome 
(uveoparotid fever) consists of uveitis, parotid gland enlarge-
ment and facial nerve palsy. Conjunctival involvement is the 
second most common ocular finding and can lead to kerato-
conjunctivitis sicca. Eye involvement can be serious, leading 
to adhesions between the iris and lens, cataract formation, 
glaucoma and blindness. 
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The peripheral lymph nodes are involved in 50 to 75% of 
patients; most commonly the cervical, axillary, epitrochlear 
and inguinal nodes1• It is important to remember that sarcoid-
like granulomas may occur in lymph nodes that drain a nearby 
malignant tumor. The spleen can be involved in up to 60% of 
patients, but symptoms occur only in the 15% of patients who 
demonstrate splenomegaly'. 
Liver biopsies have indicated involvement in 60 to 90% of 
patients2• The periportal regions are the most often affected by 
the granulomas. Cholestasis is rare, yet mild elevations of 
liver enzymes (alkaline phosphatase and serum bilirubin) are 
not uncommon. 
Neurologic findings are present in 5% of patients1• Space-
occupying granulomatous lesions of the cerebrum may cause 
confusion, seizure activity, hydrocephalus or hemiparesis. 
These mass lesions are most common at the base of the cere-
brum and can elicit symptoms and signs related to derange-
ment of the hypothalamic-pituitary axis. Chronic aseptic gran-
ulomatous meningitis has been recorded. Cranial and periph-
eral nerves are frequently involved, whereas spinal cord 
involvement is rare. 
Cardiac symptoms are present in 5% of patients 1• At autop-
sy, 27% of patients with systemic sarcoidosis have cardiac 
granulomatous lesions. The most common cardiac symptom is 
an arrhythmia caused by granulomas in the septum and ventri-
cles. Sudden cardiac death may occur, and at autopsy these 
patients are found to have massive fibrosis and granulomatous 
involvement of the myocardium. 
Kidney involvement is rare. Renal disease is usually due to an 
alteration in calcium metabolism, not to granuloma formation. 
Sarcoid granulomas of the bone marrow have been report-
ed in 15 to 40% of cases, although their effects on 
hematopoiesis are minimaF. 
Diagnosis 
The diagnosis of sarcoidosis is usually based on the 
patient's clinical presentation, the primary ancillary test being 
a chest X-ray which, in at least 25% of patients, may be the 
only evidence of disease. The classic findings of Lofgren's 
Syndrome are adequate for a diagnosis of sarcoidosis•. Of 
utmost importance is the demonstration of noncaseating gran-
ulomas which must be differentiated from the granulomas of 
tuberculoid leprosy and foreign body reaction. Biopsies of 
skin or accessible lymph nodes are the most obvious choice to 
verify the existence of granulomata. If these sites are not 
revealing, bronchoscopic biopsies may be considered. Oph-
thalmologic examination and pulmonary function tests should 
be performed on all patients. The traditional Kveim test is 
rarely performed at present because the extract is not available 
and it lacks specificity. 
ACE may be elevated. Produced by the epithelioid histio-
cytes of the granulomas, it is not a specific marker for sarcoido-
sis and is elevated in many of the diseases that fall within the 
differential diagnosis of sarcoidosis'·". Sarcoidosis is a well-
known cause of hypercalcemia. 
Two specialized tests include broncho-alveolar lavage and 
the Gallium-67 lung scan. These are used in centers that regu-
larly see patients with sarcoidosis. Lavage is done to ascertain 
the preponderance of lymphocytes, the majority of which are 
T-4 1• This may be of aid in differentiating sarcoidosis from 
(Continued on page 210) >-
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allergic alveolitis in which there is also a marked increase in 
the lymphocyte population; however, these are T-8 (suppres-
sor) lymphocytes3• The Gallium-67 scan will often display a 
diffuse uptake consistent with the interstitial disease process of 
sarcoidosis. However, the scan is not specific; it is expensive 
and exposes the patient to a significant amount of radiation3• 
Differential diagnosis 
The early chest X-ray changes of sarcoid can mimic tuber-
culosis, lymphoma and metastatic carcinoma, as well as sys-
temic fungal diseases, most notably histoplasmosis and coc-
cidiodomycosis. More advanced lung disease demonstrates 
changes on X-ray similar to that of extrinsic allergic alveolitis, 
fibrosing alveolitis, histiocytosis, systemic lupus erythemato-
sus, rheumatoid lung, scleroderma and tuberculosis. On chest 
X-ray the most advanced disease can be confused with tuber-
culosis, bullous emphysema, bronchiectasis and melioidosis6 • 
Furthermore, berylliosis, asbestosis, the diseases caused by 
silica, talc, mineral oil, and certain drugs (methotrexate, cro-
molyn sodium) can produce granulomatous lung disease and 
evoke a granulomatous response in lymph nodes but rarely in 
the skin. 
Certain infectious diseases, apart from those already enu-
merated, are likely to provoke a granulomatous response in 
lymph nodes alone. These include toxoplasmosis, infectious 
mononucleosis, brucellosis, chlamydia, pneumocystis carinii, 
tularemia, various fungi, all stages of syphilis, the fairly early 
stages of cat scratch disease and lymphogranuloma venereum. 
Granulomas may arise in the bowel and mesenteric lymph 
nodes in Crohn's Disease, Whipple's Disease, and infection 
caused by Yersinia enterocolitica. Malignant tumors may 
evoke a sarcoid-like response in adjacent lymph nodes. 
Many of the aforementioned entities can also produce gran-
ulomas in the skin. Further causes of skin granulomas include 
insect bites, delayed hypersensitivity reactions, leprosy, acne 
rosacea, granuloma annulare, tertiary syphilis, and pricks by 
sea urchins and by plants with spikes. 
Sarcoid arthritis may be confused with gout, acute 
rheumatic fever, tuberculosis, Yersinia enterocolitica arthritis, 
and rarely rheumatoid arthritis. 
Treatment and prognosis 
Treatment is initiated depending on the severity of sys-
temic or organ disease'.J. Therapy is not required for patients 
who present with an incidental bilateral hilar adenopathy on 
chest X-ray but are otherwise asyptomatic. Likewise, those 
presenting with an acute onset with some or all of the mani-
festations of Lofgren's Syndrome rarely require treatment 
because 80% will experience spontaneous resolution in any 
case. 
Of all organ systems, the lung is the most often involved 
and the disease activity must be assessed fully. In most cases, 
clinical examination, pulmonary function tests, and chest X-
ray will be sufficient. The chest X-ray findings are classically 
divided into 5 grades: Grade 0 - absence of abnormal radio-
graphic findings; Grade I - bilateral hilar adenopathy without 
involvement of lung parenchyma; Grade II - bilateral hilar 
adenopathy and parenchymal infiltration; Grade III - wide-
spread parenchymal infiltration without hilar adenopathy; 
Grade IV irreversible fibrosis with the formation of bullae'. 
Treatment must be initiated in patients with Grade II disease if 
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they are symptomatic or if more specialized studies (Gallium-
67 scan or broncho-alveolar lavage) in asymptomatic patients 
establish an increase in the activity of the disease process. 
Corticosteroids are the drug of choice for most patients 
with pulmonary and extrapulmonary disease (uveitis, cardiac 
arrhythmias, neurologic lesions and arthritis). Chloroquine 
and hydroxychloroquine are occasionally efficacious in the 
various skin manifestations associated with sarcoidosis, in 
particular lupus pernio. Interestingly, both corticosteroids and 
chloroquine tend to lower high serum calcium levels by 
inhibiting the action of active Vitamin D on the gut and also 
by inactivating the compound itself. This in turn will reduce 
the urinary excretion of calcium and prevent stone formation. 
The prognosis in sarcoidosis is good. However, in perhaps 
15% of patients the disease follows a chronic, persistent or 
recurrent course. Death directly related to sarcoidosis occurs 
in up to 6% of patients4• 
Conclusion 
Sarcoidosis, a common disease in the U.S. and various 
parts of Europe, is very rarely encountered in Hawaii. Most 
physicians here have never seen a case in our state. Diagnosis 
may be difficult, and in fact may not even be considered. Both 
tuberculosis and leprosy can present with granulomatous skin 
lesions remarkably similar to sarcoidosis2•7·". 
Skin involvement by either tuberculoid leprosy or sar-
coidosis often cannot be differentiated, clinically or histologi-
cally one from the other. However, lepromatous leprosy usual-
ly presents with few or no granulomata, and macrophages 
tend to be packed with acid fast mycobacteria. Even so, the 
skin lesions of lepromatous leprosy can be difficult to differ-
entiate clinically from sarcoidosis because they tend to present 
in the form of symmetric and bilateral plaques, nodules, or 
papules; erythema nodosum-like lesions may appear during 
reactional states". Hypaesthesia is usually present in the skin 
lesions of tuberculoid leprosy yet not in those of sarcoidosis. 
Additional problems are encountered in distinguishing the 3 
intermediate forms of leprosy: Borderline tuberculoid, border-
line, and borderline lepromatous leprosy. In these situations, 
both the clinical and histologic appearance of the involved 
skin may be an exact replica of sarcoidosis. 
In summary, we have described the first case of sarcoidosis 
to be reported from Hawaii. Undoubtedly, others have been 
seen but have not been documented in the medical literature. 
With the ever-increasing influx of residents to Hawaii from 
endemic areas, more cases of sarcoidosis are bound to be seen 
by physicians in the state. 
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